Publications by authors named "Geert R D'Haens"

Claim this Profile
I
Immunogenicity and Efficacy of Subcutaneous Infliximab Monotherapy vs Combination Therapy in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
Suzanne I Anjie, Krisztina B Gecse, Chiara M Meloni, Andrés Vidal-Itriago, Mark Löwenberg, Geert R D'Haens

Clin Gastroenterol Hepatol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vedolizumab in early and late Crohn's disease (LOVE-CD): a phase 4 open-label cohort study.
Geert R D'Haens, Mark Löwenberg, Filip Baert, Peter Bossuyt, Tamás Molnár

Lancet Gastroenterol Hepatol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and pharmacokinetics of SOR102, an oral bispecific inhibitor of TNF and interleukin-23 in healthy participants and patients with ulcerative colitis: a first-in-human, double-blind, randomised, placebo-controlled, phase 1 trial.
Vipul Jairath, Silvio Danese, Geert R D'Haens, Brian G Feagan, Laurent Peyrin-Biroulet

Lancet Gastroenterol Hepatol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of Sphingosine-1-phosphate receptor modulator treatment on leukocyte subsets across different clinical indications: A systematic review.
Dimitrios Nikolakis, Christoph Teichert, Joep Grootjans, Marleen G H van de Sande, Geert R D'Haens

Autoimmun Rev· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kinetics of intestinal ultrasound and shear-wave elastography to assess early response in ulcerative colitis patients treated with filgotinib.
Maarten Jan Pruijt, Christoph Teichert, Floris Antonius De Voogd, Reimer Jacques Janssen, Mark Löwenberg, Geert Renaat D'Haens

J Crohns Colitis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and rationale for the VICTRIVA study: A randomized, double-blind, phase 3b study of vedolizumab in combination with upadacitinib in Crohn's disease.
Silvio Danese, Bruce E Sands, Brian G Feagan, Vipul Jairath, Remo Panaccione, Geert R D'Haens

Contemp Clin Trials Commun· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An International Consensus on Appropriate Management of Corticosteroids in Clinical Trials in Inflammatory Bowel Disease.
Jurij Hanžel, Virginia Solitano, Sudheer Kumar Vuyyuru, Remo Panaccione, Bruce E Sands, Geert R D'Haens

Gastroenterology· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Submucosal hyper-echogenicity on intestinal ultrasound is associated with fat deposition and predicts treatment non-response in patients with ulcerative colitis.
Maarten J Pruijt, E Andra Neefjes-Borst, Floris A E De Voogd, Marilyne M Lange, Christoph Teichert, Geert R D'Haens

J Crohns Colitis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mucosal kinase activity and inflammatory profiles in inflammatory bowel disease, and in relation to tofacitinib response.
Eelco C Brand, Britt Roosenboom, Lisanne Lutter, Bea Malvar Fernandez, Savithri Rangarajan, Geert R D'Haens

J Crohns Colitis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral blood DNA methylation signatures to predict treatment response in Crohn's disease - Authors' reply.
Andrew Y F Li Yim, Evgeni Levin, Wouter J de Jonge, Peter Henneman, Jack J Satsangi, Geert R D'Haens

Lancet Gastroenterol Hepatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spatial transcriptomics and immunophenotyping uncover chronic inflammation-induced immune adaptations favoring dysplasia development in patients at risk of colitis-associated cancer.
Sofía Frigerio, Hina N Khan, Mojtaba Amini, Bregje Mol, Andra Neefjes-Borst, Geert R D'Haens

J Crohns Colitis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Higher Vedolizumab Clearance Associates with Poor Therapeutic Outcomes during Intravenous Vedolizumab Maintenance Therapy in Crohn's Disease.
Suzanne I Anjie, Geert R D'Haens, Filip Baert, Peter Bossuyt, Frank Hoentjen

Inflamm Bowel Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mucosal B Cell Expansion and Maturation Contribute to Colitis Pathogenesis.
Ivan C N Fung, Pim J Koelink, Lieven G M Mulders, Iris Admiraal, Caroline Verseijden, Geert R D'Haens

Inflamm Bowel Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Utility and Accuracy of Point-of-Care Testing for Anti-TNF Drug Monitoring and Loss of Response.
Christoph Teichert, Suzanne I Anjie, Toer W Stevens, Bayda Bahur, Kurtis R Bray, Geert R D'Haens

Inflamm Bowel Dis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Point-of-care ultrasound provides useful information in children with Crohn's disease visiting the outpatient clinic.
Elsa A van Wassenaer, Angelika Kindermann, Tim G J de Meij, Johan E van Limbergen, Geert R D'Haens

J Pediatr Gastroenterol Nutr· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of peripheral blood DNA methylation signatures to predict response to biological therapy in adults with Crohn's disease (EPIC-CD): an epigenome-wide association study.
Vincent W Joustra, Andrew Y F Li Yim, Peter Henneman, Ishtu Hageman, Tristan de Waard, Geert R D'Haens

Lancet Gastroenterol Hepatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An exploratory single-cell analysis of peripheral blood mononuclear cells from vedolizumab-treated Crohn's disease patients identifies response-associated differences among the plasmacytoid dendritic cells and classical monocytes.
Andrew Yung Fong Li Yim, Ishtu Hageman, Vincent W Joustra, Ahmed M I M Elfiky, Mohammed Ghiboub, Geert R D'Haens

Front Immunol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reliability and Responsiveness of Endoscopic Indices for Assessing Crohn's Disease Postoperative Recurrence in the PREVENT trial.
Jurij Hanzel, Sudheer K Vuyyuru, Brian Bressler, Mark A Samaan, Malcolm Hogan, Geert R D'Haens

Clin Gastroenterol Hepatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug repurposing approach for the discovery of therapeutic agents for Crohn's disease-associated intestinal fibrosis.
Dimitrios Nikolakis, Andrew Y F Li Yim, Kenneth L Overberg, Mohammed Ghiboub, Manon E Wildenberg, Geert R D'Haens

J Crohns Colitis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a novel Endoscopic ulcer Activity Score for Evaluation of Crohn's Disease (EASE-CD) using data from two randomised controlled trials.
Christopher Ma, Reena Khanna, Bryan R Maguire, Guangyong Zou, Brian Bressler, Geert R D'Haens

Lancet Gastroenterol Hepatol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TNF inhibitors affect the induction and maintenance of spike-specific B-cell responses after mRNA vaccination.
Laura Yl Kummer, Lisan H Kuijper, Laura Fernández Blanco, Amélie Bos, Christine Kreher, Geert Ram D'Haens

RMD Open· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of maintained remission at one year following appendicectomy in ulcerative colitis: post-hoc analysis of the ACCURE trial.
Eva Visser, Thomas D Pinkney, Lianne Heuthorst, Geert R D'Haens, Willem A Bemelman

Br J Surg· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and External Validation of an Endoscopic and Histologic Pouchitis Assessment Tool: The Atlantic Pouchitis Index.
Rocio Sedano, Christopher Ma, Malcolm Hogan, Mark S Silverberg, Guangyong Zou, Geert R D'Haens

Clin Gastroenterol Hepatol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of intravenous induction and subcutaneous maintenance therapy with guselkumab for patients with Crohn's disease (GALAXI-2 and GALAXI-3): 48-week results from two phase 3, randomised, placebo and active comparator-controlled, double-blind, triple-dummy trials.
Remo Panaccione, Brian G Feagan, Anita Afzali, David T Rubin, Walter Reinisch, Geert R D'Haens

Lancet· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply.
Suzanne I Anjie, Geert R D'Haens

Clin Gastroenterol Hepatol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis